The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care.
European urology. 2020 Apr 21 [Epub ahead of print]
Jasmin V Waterhouse, James H Hull, Mark Linch
Department of Oncology, University College London Cancer Institute, London, UK., Department of Respiratory Medicine, Royal Brompton Hospital, Imperial College, London, UK., Department of Oncology, University College London Cancer Institute, London, UK. Electronic address: .